📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

RNase-H-mediated silencing in the CNS proves predictably nontrivial. (2022)

First Author: Moazami MP

Attributed to: Antisense Oligonucleotide Therapy for Neuromuscular Disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.medj.2022.10.004

PubMed Identifier: 36370693

Publication URI: http://europepmc.org/abstract/MED/36370693

Type: Journal Article/Review

Volume: 3

Parent Publication: Med (New York, N.Y.)

Issue: 11

ISSN: 2666-6340